Cardinal Health Inc. recalls ESZOPICLONE 3MG 100 C4; NDC/UPC 65862096901; RX; TABLETS
Recalled June 2, 2021 · FDA recall D-0441-2021 · Cardinal Health
Hazard
CGMP Deviations: Intermittent exposure to temperature excursion during storage. · FDA Class II
Units
29 bottles
Sold at
FL, GA, SC
Description
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Product
ESZOPICLONE 3MG 100 C4; NDC/UPC 65862096901; RX; TABLETS
Manufacturer(s)
Cardinal Health Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →